• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CWWeekly May 19th 2008 Issue

CWWeekly May 19th 2008 Issue

May 25, 2008
CenterWatch Staff

Top News

i3 Research Acquires Russian CRO and i3 Innovus Creates Late Phase Business

i3 Global is solidifying its presence in Russia through the acquisition of Lege Artis, a Moscow-based contract research organization (CRO). Lege Artis conducts phase I through IV trials in Russia and also has operations in Belarus and Ukraine. The CRO is led by its founder and chief executive officer Tatjana Zwereva, M.D., Ph.D., who will stay on with i3 to run the operation. Alexander Makarkov, M.D., Ph.D., a co-founder, will also be joining i3. Lege Artis will be integrated within i3’s contract research division at i3 Research.

Quintiles Consulting Begins New Path with Eidetics Acquisition

Research Triangle Park, N.C.-based Quintiles took another step in its efforts to expand the CRO’s consulting group through the purchase of biopharma-ceutical consulting firm Eidetics. The firm will be integrated into Quintiles Consulting, a 150-employee company with experts from nearly every segment of the pharmaceutical industry. Eidetics performs health economics, decision-analytics and market research services to help sponsors maximize their products post-launch.

Other breaking news...

  • etrials reports drop in net service revenue...
  • eRT first quarter revenues soar...

Company Profile: An interview with Kazem Kazempour, Ph.D., Amarex

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing